SOFINNOVA CAPITAL VI FCPR 4
4 · HOOKIPA Pharma Inc. · Filed Mar 31, 2021
Insider Transaction Report
Form 4
SOFINNOVA CAPITAL VI FCPR
10% Owner
Transactions
- Sale
Common Stock
2021-03-26$13.69/sh−35,171$481,642→ 3,543,023 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan dated September 30, 2020 previously adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.27 to $14.03, inclusive. The reporting person undertakes to provide to Hookipa Pharma Inc., any security holder of Hookipa Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.